AAAAAA

   
Results: 1-25 | 26-50 | 51-66
Results: 1-25/66

Authors: Tanaka, M Okada, K Ueshima, S Imano, M Ohyanagi, H Carmeliet, P Matsuo, O
Citation: M. Tanaka et al., Impaired liver regeneration after partial hepatectomy in plasminogen deficient mice, FIBRINOL PR, 15(1), 2001, pp. 2-8

Authors: Carmeliet, P Conway, EM
Citation: P. Carmeliet et Em. Conway, Growing better blood vessels - A polymer scaffold that delivers two angiogenic factors with distinct kinetics shows promise for engineering mature blood vessels, NAT BIOTECH, 19(11), 2001, pp. 1019-1020

Authors: Nuyens, D Stengl, M Dugarmaa, S Rossenbacker, T Compernolle, V Rudy, Y Smits, JF Flameng, W Clancy, CE Moons, L Vos, MA Dewerchin, M Benndorf, K Collen, D Carmeliet, E Carmeliet, P
Citation: D. Nuyens et al., Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome, NAT MED, 7(9), 2001, pp. 1021-1027

Authors: Brown, EB Campbell, RB Tsuzuki, Y Xu, L Carmeliet, P Fukumura, D Jain, RK
Citation: Eb. Brown et al., In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy (vol 7, pg 864,2001), NAT MED, 7(9), 2001, pp. 1069-1069

Authors: Brown, EB Campbell, RB Tsuzuki, Y Xu, L Carmeliet, P Fukumura, D Jain, RK
Citation: Eb. Brown et al., In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy, NAT MED, 7(7), 2001, pp. 866-870

Authors: Carmeliet, P Moons, L Luttun, A Vincenti, V Compernolle, V De Mol, M Wu, Y Bon, F Devy, L Beck, H Scholz, D Acker, T DiPalma, T Dewerchin, M Noel, A Stalmans, I Barra, A Blacher, S Vandendriessche, T Ponten, A Eriksson, U Plate, KH Foidart, JM Schaper, W Charnock-Jones, DS Hicklin, DJ Herbert, JM Collen, D Persico, MG
Citation: P. Carmeliet et al., Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathologicalconditions, NAT MED, 7(5), 2001, pp. 575-583

Authors: Angelillo-Scherrer, A de Frutos, PG Aparicio, C Melis, E Savi, P Lupu, F Arnout, J Dewerchin, M Hoylaerts, MF Herbert, M Collen, D Dahlback, B Carmeliet, P
Citation: A. Angelillo-scherrer et al., Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis, NAT MED, 7(2), 2001, pp. 215-221

Authors: Carmeliet, P
Citation: P. Carmeliet, Jeffrey Michael Isner 1947-2001 - Obituary, NAT MED, 7(12), 2001, pp. 1269-1269

Authors: Nicole, O Docagne, F Ali, C Margaill, I Carmeliet, P MacKenzie, ET Vivien, D Buisson, A
Citation: O. Nicole et al., The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling, NAT MED, 7(1), 2001, pp. 59-64

Authors: Oosthuyse, B Moons, L Storkebaum, E Beck, H Nuyens, D Brusselmans, K Van Dorpe, J Hellings, P Gorselink, M Heymans, S Theilmeier, G Dewerchin, M Laudenbach, V Vermylen, P Raat, H Acker, T Vleminckx, V Van den Bosch, L Cashman, N Fujisawa, H Drost, MR Sciot, R Bruyninckx, F Hicklin, DJ Ince, C Gressens, P Lupu, F Plate, KH Robberecht, W Herbert, JM Collen, D Carmeliet, P
Citation: B. Oosthuyse et al., Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration, NAT GENET, 28(2), 2001, pp. 131-138

Authors: Dor, Y Camenisch, T Itin, A Fishman, GI McDonald, JA Carmeliet, P Keshet, E
Citation: Y. Dor et al., A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects, DEVELOPMENT, 128(9), 2001, pp. 1531-1538

Authors: Lambert, V Munaut, C Noel, A Frankenne, F Bajou, K Gerard, R Carmeliet, P Defresne, MP Foidart, JM Rakic, JM
Citation: V. Lambert et al., Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization, FASEB J, 15(6), 2001, pp. 1021-1027

Authors: Rajantie, I Ekman, N Iljin, K Arighi, E Gunji, Y Kaukonen, J Palotie, A Dewerchin, M Carmeliet, P Alitalo, K
Citation: I. Rajantie et al., Bmx tyrosine kinase has a redundant function downstream of angiopoietin and vascular endothelial growth factor receptors in arterial endothelium, MOL CELL B, 21(14), 2001, pp. 4647-4655

Authors: Holst-Hansen, C Low, JA Stephens, RW Johnson, MD Carmeliet, P Frandsen, TL Brunner, N Dickson, RB
Citation: C. Holst-hansen et al., Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat, BREAST CANC, 68(3), 2001, pp. 225-237

Authors: Carmeliet, P
Citation: P. Carmeliet, Cardiovascular biology - Creating unique blood vessels, NATURE, 412(6850), 2001, pp. 868-869

Authors: Van Cromphaut, SJ Dewerchin, M Hoenderop, JGJ Stockmans, I Van Herck, E Kato, S Bindels, RJM Collen, D Carmeliet, P Bouillon, R Carmeliet, G
Citation: Sj. Van Cromphaut et al., Duodenal calcium absorption in vitamin D receptor-knockout mice: Functional and molecular aspects, P NAS US, 98(23), 2001, pp. 13324-13329

Authors: Yang, YH Carmeliet, P Hamilton, JA
Citation: Yh. Yang et al., Tissue-type plasminogen activator deficiency exacerbates arthritis, J IMMUNOL, 167(2), 2001, pp. 1047-1052

Authors: Bajou, K Masson, V Gerard, RD Schmitt, PM Albert, V Praus, M Lund, LR Frandsen, TL Brunner, N Dano, K Fusenig, NE Weidle, U Carmeliet, G Loskutoff, D Collen, D Carmeliet, P Foidart, JM Noel, AS
Citation: K. Bajou et al., The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: Implications for antiangiogenic strategies, J CELL BIOL, 152(4), 2001, pp. 777-784

Authors: Brusselmans, K Bono, F Maxwell, P Dor, Y Dewerchin, M Collen, D Herbert, JM Carmeliet, P
Citation: K. Brusselmans et al., Hypoxia-inducible factor-2 alpha (HIF-2 alpha) is involved in the apoptotic response to hypoglycemia but not to hypoxia, J BIOL CHEM, 276(42), 2001, pp. 39192-39196

Authors: Yiou, R Delmas, V Carmeliet, P Gherardi, RK Barlovatz-Meimon, G Chopin, DK Abbou, CC Lefaucheur, JP
Citation: R. Yiou et al., The pathophysiology of pelvic floor disorders: evidence from a histomorphologic study of the perineum and a mouse model of rectal prolapse, J ANAT, 199, 2001, pp. 599-607

Authors: Heyen, MV Heymans, S Antoons, G Reed, T Periasamy, M Awede, B Lebacq, J Vangheluwe, P Dewerchin, M Collen, D Sipido, K Carmeliet, P Wuytack, F
Citation: Mv. Heyen et al., Replacement of the muscle-specific sarcoplasmic reticulum Ca2+-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart, CIRCUL RES, 89(9), 2001, pp. 838-846

Authors: Levi, M Moons, L Bouche, A Shapiro, SD Collen, D Carmeliet, P
Citation: M. Levi et al., Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice, CIRCULATION, 103(15), 2001, pp. 2014-2020

Authors: Conway, EM Collen, D Carmeliet, P
Citation: Em. Conway et al., Molecular mechanisms of blood vessel growth, CARDIO RES, 49(3), 2001, pp. 507-521

Authors: Kadambi, A Carreira, CM Yun, C Padera, TP Dolmans, DEJGJ Carmeliet, P Fukumura, D Jain, RK
Citation: A. Kadambi et al., Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular function and leukocyte recruitment: Role of VEGF-receptor 2 and host VEGF-A, CANCER RES, 61(6), 2001, pp. 2404-2408

Authors: Frandsen, TL Holst-Hansen, C Nielsen, BS Christensen, IJ Nyengaard, JR Carmeliet, P Brunner, N
Citation: Tl. Frandsen et al., Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) fin the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model, CANCER RES, 61(2), 2001, pp. 532-537
Risultati: 1-25 | 26-50 | 51-66